MarketInOut Stock Screener Log In | Sign Up

Hikal Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:55
Hikal Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization24,036 mln
Float38.08 mln
Earnings Date11/03/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.71
Likely reliable

Relative Strength

47 / 100
In line with market

Debt / Equity

0.57
Moderate leverage

Pre-Tax Margin

-3%
Barely loss-making

ROE

-2.79
Negative

Business Description

Hikal Limited is an India-based manufacturer of chemical and pharmaceutical products, serving industries that include crop protection, animal health, and life sciences. Founded in 1988 and headquartered in Navi Mumbai, the company produces active pharmaceutical ingredients, chemical intermediates, pesticides, and specialty biocides. Hikal also offers contract research and custom manufacturing services to clients across India, North America, Europe, and Southeast Asia.

Key Fundamentals

EPS-2.74
ROE-2.79
RPS141
ROIC1.81
ROA-1.39
Interest Cover1.09
EBITDA, mln1,692
EV / EBITDA19.85
EV / EBIT1,600
Revenue, mln17,350
EV / Revenue1.94

Quote Details

Last 202.10
Change 0.27 (0.13%)
Open 201.54
Volume 199,429
Turnover 40,304,604
Average Volume 379,826

Financial Ratios

Pre-Tax Profit Margin-3
Current Ratio1.30
Price / Book2.24
Price / Tangible Book2.25
Price / Cash Flow8.84
Price / Free Cash Flow33.89
Debt / Equity0.57
Price / Sales1.55

Financial Strength

Altman Z-Score2.7
Piotroski F-Score 4 / 9
Beneish M-Score-2.71
Price to Intrinsic Value22.23
Price to Graham Number5.00
Shiller PE Ratio25.28

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.11% 29 / 100   
1 Month -7.11% 51 / 100   
2 Months -9.92% 43 / 100   
6 Months 7.03% 71 / 100   
1 Year -15.57% 49 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog